Pelthos Therapeutics (PTHS) Raw Materials (2025 - 2026)
Pelthos Therapeutics (PTHS) posted quarterly Raw Materials of $436000.0 for Q4 2025.
Pelthos Therapeutics (PTHS) Raw Materials (2025 - 2026) Analysis & Trends
Pelthos Therapeutics' Raw Materials history runs 1 years deep, the most recent figure standing at $436000.0 for Q4 2025.
- In Q4 2025, Raw Materials changed N/A year-over-year to $436000.0; the TTM figure through Dec 2025 stood at $436000.0 (changed N/A YoY), while the FY2025 annual figure was $436000.0, changed N/A from the prior year.
- Raw Materials for Q4 2025 stood at $436000.0.
- The five-year high for Raw Materials was $436000.0 in Q4 2025, with the low at $436000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.79 Bn | 130.93 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.99 Bn | 78.00 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.26 Bn | 60.07 Bn | 1.37 Bn |
| 4 | Moderna | 56.04 Bn | 50.91 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.05 Bn | 36.95 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.71 Bn | 28.40 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.66 Bn | 9.26 Bn | 668.28 Mn |
| 8 | Insmed | 27.50 Bn | 26.33 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.35 Bn | 26.52 Bn | - |
| 10 | Pelthos Therapeutics | 93.05 Mn | 68.49 Mn | 21.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 668,000.00 |
| Dec 31, 2025 | 436,000.00 |